Novel GEM Models For Exploring Neurodegenerative Disease Therapeutics

Time: 11:50 am
day: Track B - Day 1 AM

Details:

  • Challenges with in vivo models for neurodegenerative disease drug development
  • Key attributes of successful CNS disease in vivo models
  • Developing in vivo models for neurodegenerative drug
    screening

Speakers: